AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
08:15
Several Ukrainian soldiers may have deserted during training in Germany
07:56
The United States has announced new sanctions against Cuba / Washington accuses Havana of supporting a "subversive network" that seeks to expand its influence in America.
07:54
The interim Minister of Labor, Dragoș Pîslaru, about the Salary Law: "We have explored all possible options to achieve social acceptability, respecting the fiscal-budgetary reality of Romania."
07:34
Donald Trump threatens with the economic isolation of Iran.
07:30
President of Serbia Aleksandar Vucic announced the organization of early legislative elections in Serbia / The vote could take place on October 18 or 25
See more news